18 Sep 2014
Washington: Using the sound waves of an ultrasound to detect a painful kidney stone is just as effective as the X-rays of a CT scan, and exposes patients to much less harmful radiation, according to a new multicenter study.
01 Sep 2014
New York: In what could offer to be a more reliable way to detect malaria, researchers have devised a Magnetic Resonance Imaging-like (MRI) technique that can do away with potential human error possible in conventional malaria diagnosis.
27 Apr 2013
Scientists have found a way of detecting and quantifying an infant's risk of autism in the womb itself, says a new study conducted by scientists in the US.
26 Aug 2014
Washington: New research shows that children exposed to gestational diabetes in the wombs are nearly six times more likely to develop diabetes or prediabetes than children who are not exposed.
28 Mar 2014
New York: Conditions for autism may develop even before birth, in the second and third trimester of pregnancy, a new study has found.
08 Apr 2014
New Delhi: A new study reveals that autism may begin during a baby’s early development in the womb. Researchers at the University of California, San Diego School of Medicine and the Allen Institute for Brain Science autism have published a study that gives clear and direct new evidence that autism begins during pregnancy.
26 Jul 2014
Washington: The act of making eye contact with another person to share an experience without a smile can predict later autism symptoms in babies, a new study has found.
18 Aug 2014
New York: Researchers have devised a way to analyze genome sequences in what could help physicians map the risk of various afflictions, including cancer and autism.
23 May 2014
New York: Spotting the early warning signs of autism has just become a bit easier for parents and physicians with a software that tracks and records infants' activity during videotaped autism screening tests.
05 Jul 2014
New York: Scientists have stumbled upon a chemical ‘switch’ in the brains of Alzheimer's and stroke patients that prevents the generation and survival of neurons. The chemical switch, MEF2, may be a potential therapeutic target to protect against neuronal loss in a variety of neurodegenerative diseases such as Alzheimer's, Parkinson's and autism, researchers said.